Synonyms: AR-1I9514 | Arbidol®
Compound class:
Synthetic organic
Comment: Umifenovir is an indole-based antiviral drug. It is a viral entry inhibitor [3] and also acts to modulate the host immune response (induces interferon-production, stimulates macrophages phagocytosis).
|
|
No information available. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04350684 | Umifenovir in Hospitalized COVID-19 Patients | Phase 4 Interventional | Shahid Beheshti University of Medical Sciences | ||
NCT04286503 | The Clinical Study of Carrimycin on Treatment Patients With COVID-19 | Phase 4 Interventional | Beijing YouAn Hospital | ||
NCT03787459 | Severe Influenza Trial of ARbidol | Phase 3 Interventional | Capital Medical University |